Treating Active Pharmaceutical Ingredients in Manufacturing Wastewater

  20 February 2020

Pharmaceutical medicines play a critical role in human and animal health. However, in recent years, there is growing evidence that active pharmaceutical ingredients (APIs) are accumulating in rivers, lakes, and drinking water worldwide and impacting aquatic ecosystems. As a result, pharmaceuticals in the environment (PiE) has emerged as a global health risk according to the UN, WHO, European Commission, and World Economic Forum. 

Leading pharmaceutical manufacturers have taken steps to tackle this issue by collaborating with researchers, nonprofits, and international agencies to develop and implement new, innovative solutions across the pharmaceutical value chain. Meanwhile, governments have generally been slow to react with clear guidelines, regulations, and oversight. 

 

Further reading: Water Technology
Author(s): Jonathan Rhone
Clean Environment  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!